Novartis, for instance, recently won FDA approval for FlucelVax, which uses animal cell culture instead of traditional manufacturing that uses chicken eggs, a faster production process that can hasten stockpiling.
FORBES: The Flu Season Is A Shot In The Arm For Vaccine Makers?